Biobot Analytics, Inc. is a for-profit biotechnology company based in Cambridge, Massachusetts, known as a leader in wastewater epidemiology and public health analytics.
Subscribe to see Biobot Analytics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Biobot Analytics, Inc. is a biotechnology company headquartered in United States. It has raised at least $41M across the 3 funding rounds on record. Its most recent funding round raised $13.5M in May 2025. Xcout tracks 10 named people at Biobot Analytics, Inc., including Mariana Matus (CEO).
4 more named people on record for Biobot Analytics, Inc., with roles, board committees and tenure — see the full roster →
At least $41M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $13.5M | — | |
| SEC Form D filing | $20.8M | — | |
| SEC Form D filing | $6.7M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Biobot Analytics, Inc.'s closest competitors — see the full list of competitors and alternatives →
Binx health Ltd. is based in Cambridge, Massachusetts, and offers healthcare services including at-home sample collection and contactless courier services.
LymeAlert is pioneering early-detection technology for Lyme disease, designed to bring faster diagnosis and hope to millions affected by tick-borne illness. Operating in the public health sector, the private company is headquartered in Cambridge, Massachusetts.
Mercy BioAnalytics, Inc. is a privately held biotechnology company founded in 2018 and headquartered in Waltham, Massachusetts. The company is dedicated to developing early diagnostics and detection technologies.
Liquid BioScience, Inc. is a biotechnology company operating within the United States, focusing on advanced analytics and diagnostics in the biotech sector.
SunBird Bio, Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, focused on developing blood-based diagnostic tests for neurological and oncological diseases.
Glympse Bio is a biotechnology company headquartered in Cambridge, Massachusetts. The company serves as a primary center for research and development, clinical operations, and strategic partnerships in the life sciences sector.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.